NCT02823600View on ClinicalTrials.gov

Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Kidney Failure, ChronicEye DiseasesDiabetic Retinopathy
Interventions
DEVICE

RetinaVue 100 camera

Images of the subject's eye will be obtained using the RetinaVue 100 camera and uploaded to a secure network. The study doctor, a board-certified ophthalmologist, will interpret the patient images and return a diagnosis and management plan to the dialysis unit.

Trial Locations (1)

27599

UNC Ophthalmology, Chapel Hill

All Listed Sponsors
collaborator

Welch Allyn

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT02823600 - Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers | Biotech Hunter | Biotech Hunter